The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patient

[Guest guest]

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-Term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.

http://clinicaltrials.gov/ct/show/NCT00354627?order=1

Regards, Vergelsalvagetherapies dot org